Close



Oct 30, 2020 07:00AM
Aug 31, 2020 08:53AM
Aug 4, 2020 04:05PM
Jul 22, 2020 07:13AM
Jul 22, 2020 07:00AM
Jun 8, 2020 07:02AM
Jun 8, 2020 07:00AM Akcea announces approval for reimbursement of TEGSEDI® (inotersen) in Italy for treatment of hereditary transthyretin amyloidosis with polyneuropathy
Jun 1, 2020 07:10AM
Jun 1, 2020 07:00AM
May 28, 2020 07:11AM
May 28, 2020 07:00AM
May 28, 2020 07:00AM
May 14, 2020 04:07PM
May 14, 2020 04:05PM Akcea Announces Approval for Reimbursement of TEGSEDI® (inotersen) in Spain for Treatment of Hereditary Transthyretin Amyloidosis with Polyneuropathy
May 6, 2020 07:00AM
May 5, 2020 04:05PM
Feb 25, 2020 04:05PM
Feb 25, 2020 04:05PM
Aug 29, 2019 07:00AM
Aug 29, 2019 07:00AM
Aug 7, 2019 07:00AM Ionis Reports Second Quarter 2019 Financial Results
Jun 26, 2019 07:00AM
Jun 26, 2019 07:00AM
Jun 20, 2019 04:38PM
Jun 20, 2019 04:38PM
May 7, 2019 04:05PM
May 7, 2019 04:05PM
May 2, 2019 07:05AM Akcea Announces Upcoming Data Presentations at the 2019 American Academy of Neurology Meeting (AAN.19)
May 2, 2019 07:05AM
Mar 15, 2019 04:06PM
Mar 15, 2019 04:05PM
Mar 15, 2019 04:05PM
Nov 29, 2018 07:00AM
Nov 29, 2018 07:00AM
Nov 12, 2018 06:58AM Akcea Therapeutics (AKCA), Ionis Pharmaceuticals, Inc. (IONS) Highlight Phase 2 Results on AKCEA-APO(a)-LRx in Late-Breaking Clinical Trial Presentation
Nov 12, 2018 06:55AM
Nov 12, 2018 06:55AM
Nov 8, 2018 07:37AM
Nov 8, 2018 07:00AM
Nov 8, 2018 07:00AM
Nov 5, 2018 04:05PM
Nov 5, 2018 04:05PM Akcea Reports Financial Results and Highlights for Third Quarter 2018
Oct 9, 2018 08:49AM
Oct 8, 2018 06:16AM
Oct 5, 2018 05:33PM
Oct 5, 2018 05:33PM
Oct 5, 2018 05:32PM
Oct 5, 2018 05:32PM
Sep 24, 2018 07:05AM Ionis Pharmaceuticals (IONS) Affiliate Akcea Therapeutics, Inc. (AKCA) Announces Positive Data from Phase 2 Study of AKCEA-APO(a)-LRx
Sep 24, 2018 07:00AM

251,395 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All